Contact
Please use this form to send email to PR contact of this press release:
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
TO:
Please use this form to send email to PR contact of this press release:
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
TO: